VeriMomVeriMom
HIGH RISK

Hamilelikte sassafras officinale bark extract kullanmaktan kaçınmalı mıyım? | VeriMom

Sassafras bark/root extracts can contain the alkenylbenzene safrole, which is harmonised/classified in the EU as a carcinogen (CLP Category 1B/H350/H351) and is prohibited in cosmetics; carcinogenic/mutagenic hazards are treated as high reproductive concern. Safrole’s metabolic activation leads to DNA adduct formation (demonstrated mechanism). Exposure from topical cosmetic use is low–but measurable unless the extract is guaranteed safrole-free. (ECHA substance data; NTP/Report on Carcinogens; PubMed reviews of alkenylbenzenes).

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

sassafras officinale bark extract hamilelikte güvenli mi?
Sassafras bark/root extracts can contain the alkenylbenzene safrole, which is harmonised/classified in the EU as a carcinogen (CLP Category 1B/H350/H351) and is prohibited in cosmetics; carcinogenic/mutagenic hazards are treated as high reproductive concern. Safrole’s metabolic activation leads to DNA adduct formation (demonstrated mechanism). Exposure from topical cosmetic use is low–but measurable unless the extract is guaranteed safrole-free. (ECHA substance data; NTP/Report on Carcinogens; PubMed reviews of alkenylbenzenes).
sassafras officinale bark extract emzirirken güvenli mi?
Same basis as pregnancy: presence of safrole (harmonised EU classification as a CMR) makes the ingredient high hazard for lactation context. Topical exposures are low–but measurable; transfer into milk is not well characterised for cosmetic topical use, but CMR classification and genotoxic mechanism justify a high hazard rating. (ECHA; NTP; SCF/PubMed reviews).
sassafras officinale bark extract bebek cildi için güvenli mi?
Hazard and mechanism mirror adult/pregnancy because safrole is a harmonised CMR 1B. Exposure score is increased for infants (+1) because infant skin has higher surface-area-to-weight and less mature barrier, so a measurable topical exposure becomes a moderate exposure for 0–3 yr. Where the extract is confirmed safrole-free, these scores would change. (ECHA; NTP; PubMed reviews).
VeriMom sassafras officinale bark extract nasıl puanlıyor?
VeriMom sassafras officinale bark extract'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 20/100 (yüksek risk) olarak puanlar.
Hamilelikte sassafras officinale bark extract yerine neler kullanılabilir?
Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.

Her etiketi 2 saniyede kontrol et

VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.

Tıbbi Sorumluluk Reddi

Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.

VeriMom uygulamasında tüm özellikleri keşfedin